Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
Ishigami S, Arigami T, Uenosono Y, Matsumoto M, Okumura H, Uchikado Y, Kita Y, Nishizono Y, Maemura K, Kijima Y, Nakajo A, Owaki T, Ueno S, Hokita S, Natsugoe S. Ishigami S, et al. Among authors: maemura k. Cancer Immunol Immunother. 2012 Oct;61(10):1663-9. doi: 10.1007/s00262-012-1225-5. Epub 2012 Feb 29. Cancer Immunol Immunother. 2012. PMID: 22374482 Free PMC article.
Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
Ishigami S, Uenosono Y, Arigami T, Yanagita S, Okumura H, Uchikado Y, Kita Y, Kurahara H, Kijima Y, Nakajo A, Maemura K, Natsugoe S. Ishigami S, et al. Among authors: maemura k. World J Surg Oncol. 2014 Nov 18;12:350. doi: 10.1186/1477-7819-12-350. World J Surg Oncol. 2014. PMID: 25407392 Free PMC article.
Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.
Ishigami S, Arigami T, Okumura H, Uchikado Y, Kita Y, Kurahara H, Maemura K, Kijima Y, Ishihara Y, Sasaki K, Uenosono Y, Natsugoe S. Ishigami S, et al. Among authors: maemura k. Anticancer Res. 2015 Apr;35(4):2279-85. Anticancer Res. 2015. PMID: 25862890
Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.
Amatatsu M, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kijima Y, Kurahara H, Kita Y, Mori S, Sasaki K, Omoto I, Maemura K, Ishigami S, Natsugoe S. Amatatsu M, et al. Among authors: maemura k. Cancer Sci. 2018 Mar;109(3):814-820. doi: 10.1111/cas.13508. Epub 2018 Feb 19. Cancer Sci. 2018. PMID: 29345842 Free PMC article.
633 results